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ABSTRACT: Human α-defensin 6 (HD6) is a 32-aa cysteine-rich
peptide of the innate immune system. Although HD6 is a member
of an antimicrobial peptide family, it exhibits negligible antibacterial
activity in vitro. Rather, HD6 possesses a unique innate immune
mechanism whereby it self-assembles into oligomers that capture
pathogens to prevent microbial invasion of the intestinal epithelium
and subsequent dissemination. Molecular-level understanding for
why HD6 functions diﬀerently from other human defensins remains
unclear. To further elucidate the HD6 self-assembly process and its
biological activity, we developed robust protocols for obtaining
native and mutant HD6 in high purity from overexpression in Escherichia coli. We combined biophysical characterization with
biological assays to probe HD6 structure and function. We report that native HD6 readily self-assembles into elongated ﬁbrils
observable by transmission electron microscopy, agglutinates both Gram-negative and -positive bacteria, and prevents the human
gastrointestinal pathogen Listeria monocytogenes from invading cultured mammalian cells. Mutation of hydrophobic residues
(F2A, I22T, V25T, F29A) perturbs self-assembly and results in attenuated biological activity. In particular, the F2A and F29A
mutants do not form ﬁbrils under our experimental conditions and neither agglutinate bacteria nor prevent L. monocytogenes
invasion. In total, our results demonstrate that the hydrophobic eﬀect is essential for promoting HD6 self-assembly and innate
immune function, and indicate that HD6 may provide host defense against Listeria in the gut. This investigation provides a timely
description of how variations in amino acid sequence confer diverse physiological functions to members of the defensin family.
■ INTRODUCTION
The innate immune system provides the ﬁrst line of defense for
the detection of and response to microbial invasion. One of the
key contributors to innate immunity is a family of small (2−5
kDa), cysteine-rich host-defense peptides called defensins.1−5
These biomolecules are typically described as antimicrobial
peptides with broad-spectrum microbicidal activity. In the
oxidized forms, mammalian defensins contain three conserved
and regiospeciﬁc intramolecular disulﬁde bonds that stabilize a
three-stranded β-sheet fold.5 The regiospeciﬁc disulﬁde-bond
patterns divide these defensins into three subclasses called α-,
β-, and θ-defensins. Humans produce and utilize α- and β-
defensins in the battles against invading microbial pathogens.
The six α-defensins identiﬁed in humans are human
neutrophil peptides 1−4 (HNP1−4) and human enteric
defensins 5 and 6 (HD5 and HD6).6 These peptides exhibit
CysI−CysVI, CysII−CysIV, CysIII−CysV linkages following
oxidative folding. HNP1−4 are stored in the azurophilic
granules of neutrophils,7,8 human monocytes,9 and natural killer
cells.10 HD5 and HD6 are abundant in the granules of Paneth
cells,11−14 a type of secretory cell located at the bases of the
crypts of Lieberkühn in the small intestine.15,16 Paneth cells
protect the intestinal epithelium against infection and
colonization of opportunistic and pathogenic microbes by
secreting a mixture of antimicrobial peptides and proteins that
includes HD5 and HD6.15,16
Although the six human α-defensins display a common
tertiary structure that results from conserved cysteine position-
ing and the regiospeciﬁc disulﬁde array,2,5 the primary
sequences are highly variable and several recent studies
demonstrated that α-defensins possess diﬀerent structural and
functional attributes.17−24 A comparison of the 32-residue
Paneth cell defensins HD5 and HD6 exempliﬁes this
notion.19−24 HD5 forms dimers and tetramers in aqueous
solutions20,25 and provides broad-spectrum antibacterial activity
in vitro.22,23 The HD5 transgenic mouse exhibits resistance to
oral Salmonella challenge.24 In contrast, HD6 displays negligible
antibacterial activity in vitro;21,22 however, studies of the HD6
transgenic mouse revealed that this peptide provides defense
against Salmonella challenge by an unprecedented mecha-
nism.21 In the current working model, HD6 forms higher-order
structures described as “nanonets” that entrap bacteria in the
intestinal lumen and thereby prevent bacterial invasion of the
host epithelium and subsequent dissemination to other organ
systems.21 This remarkable observation gives rise to a number
of questions about HD6 at the molecular level. Why does HD6
function diﬀerently from other human α-defensins, including its
Paneth cell congener HD5? What is the molecular basis for
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HD6 self-assembly that aﬀords “nanonets” from 32-residue
monomeric units?
Several recent studies support the importance of the
hydrophobic eﬀect for the in vitro biological activities of α-
defensins, including HNP1, HD5, and murine cryptdin-4.25−28
The amino acid sequence alignment of the six human α-
defensins reveals that the distribution of hydrophobic residues
in the HD6 primary sequence is distinct from those in HD5
and the HNPs (Supporting Information Figure S1). Prior X-ray
crystallographic structural studies indicate that several hydro-
phobic residues of HD5 reside on the β-sheets and facilitate
side-to-side dimerization (PDB: 1ZMP,19 Supporting Informa-
tion Figure S2), whereas the hydrophobic residues of HD6
(PDB: 1ZMQ,19 Supporting Information Figure S2) are
located in the loop (V22, M23, I25) and in the N- (F2) and
C-terminal regions (F29, L32). Moreover, the hydrophobic
residues of HD6 deﬁne a hydrophobic pocket that forms at the
interface between four monomers.19,25 In each hydrophobic
pocket, two monomers each contribute F2, F29, and L32, and
the other two monomers each contribute V22, M23, and I25.
Although each HD6 monomer exhibits the canonical α-
defensin fold in the solid state, the monomers assemble to
form an elongated ﬁbril-like chain that is unique among
structurally characterized defensins (Figure 1A).19,21 We
reasoned that formation of this hydrophobic pocket allows
HD6 monomers to form the elongated ﬁbril-like structures
observed crystallographically (Figure 1A,B), and hypothesized
that the hydrophobic eﬀect also contributes to formation of the
nanonet structures observed in biological systems.
In the present work, we describe biochemical and biophysical
studies designed to investigate the self-assembly and biological
function of HD6. We report that native HD6 forms micron-
sized ﬁbril structures in aqueous solution, agglutinates bacteria,
and prevents Listeria monocytogenes invasion into cultured
human cells. We demonstrate that hydrophobic residues,
especially F2 and F29, are essential for self-assembly under
the experimental conditions utilized in this work and provide
HD6 with the ability to entrap bacteria and prevent invasive
microbes from entering human cells. In total, our investigations
provide important new molecular-level insight into a host-
defense peptide with an unprecedented physiological activity
and support a model whereby the disposition of hydrophobic
residues along the canonical α-defensin fold tunes innate
immune function. Moreover, the gut is a primary site for L.
monocytogenes infection and our results suggest that HD6 may
confer host defense against this pathogen in the gut.
■ RESULTS AND DISCUSSION
Design and Preparation of a HD6 Mutant Family. We
designed and prepared a six-membered HD6 mutant family
(Figure 1C, Supporting Information Table S1) to evaluate the
role of select residues in HD6 self-assembly and host-defense
function. The mutants F2A, F29A, V22T, and I25T were
prepared to probe the consequences of decreased hydro-
phobicity for each of these residues. We also evaluated H27W
and H27A. This residue abuts the hydrophobic pocket and, in
prior work, a role for H27 in self-assembly was proposed from
evaluation of the H27W and H27A mutants.21 The X-ray
crystal structure of H27W (PDB: 3QTE)21 diﬀers from that of
Figure 1. (A) Previously reported extended crystal structure of HD6 (PDB: 1ZMQ).19 Hydrophobic residues are shown in orange. Inset: a HD6
monomer unit illustrates the three-stranded β-sheet fold. The disulﬁde bonds are shown in yellow. (B) Close-up view of the hydrophobic pocket
located among HD6 monomers. Individual HD6 monomers are labeled A−D. (C) Amino acid sequences of HD6 and mutants evaluated in this
work. The numbers represent amino acid position. The Cys residues in blue comprise the Cys4−Cys31, Cys6−Cys20, and Cys10−Cys30 disulﬁde
linkages (solid lines). The salt-bridge between Arg7 and Glu14 is indicated as a dashed line. The mutated residues are shown in red. The secondary
structure depiction is based on the crystal structure. (D) Analytical HPLC traces of puriﬁed HD6 and mutants (oxidized forms) dissolved in Milli-Q
water (30 μM × 80 μL). Absorbance at 220 nm was monitored with a reference wavelength of 500 nm. Method: 10−60% B over 30 min at 1 mL/
min.
Journal of the American Chemical Society Article
dx.doi.org/10.1021/ja5057906 | J. Am. Chem. Soc. 2014, 136, 13267−1327613268
HD6 and supports a dimer of dimers arrangement and the
absence of elongated structures. An electrostatic interaction
between H27 of one monomer (A or D, Supporting
Information Figure S3) and the C-terminal carboxylic acid of
L32 of another monomer (B or C, Supporting Information
Figure S3) was hypothesized to enable formation of the
extended oligomers observed for native HD6.21 The X-ray
crystal structure of HD6 also suggests that a π−π stacking
interaction between the side chains of F2 of one monomer (A
or D) and H27 of another monomer (B or C) may occur and
contribute to self-assembly (Supporting Information Figure
S3).
In prior studies of HD5, we overexpressed His6-Met-HD5
and employed cyanogen bromide to cleave the aﬃnity tag and
aﬀord native HD5.29 HD6 contains a Met residue at position 23
and is not compatible with this approach. The HNPs and HD5
are transcribed and translated as prepropeptides that undergo
maturation,30−32 and mRNA analysis indicates that HD6 is
translated as a prepropeptide (100-aa), as well.12 We therefore
expressed proHD6 (81-aa) harboring a N-terminal His6 tag and
released native HD6 (oxidized form) by protease digestion
(Supporting Information). For peptide overexpression, an
Escherichia coli-optimized synthetic gene for proHD6 was
ligated into the NdeI and XhoI sites of pET28b, and His6-
proHD6 was overexpressed in E. coli BL21(DE3) cells and
isolated by using Ni-NTA column chromatography. The
oxidized form of His6-proHD6 was obtained by following an
oxidative folding protocol,29 and native HD6 was isolated
following treatment of His6-proHD6 with trypsin and
preparative HPLC puriﬁcation (Supporting Information Figure
S4). We employed the same procedure to prepare the six HD6
mutants. Analytical HPLC indicated that HD6 and mutants
were obtained in high purity (Figure 1D, Supporting
Information Figure S5). The peptide yields ranged from 1.8
(F2A) to 4.5 (H27W) mg/L of culture (Supporting
Information Table S2). Thiol quantiﬁcation indicated that
each peptide contained no free thiol moieties (Supporting
Information Table S2), and the peptide identities were
conﬁrmed by LC−MS (Supporting Information Table S2).
For each mutant, the canonical α-defensin disulﬁde bond
Figure 2. Biophysical characterization of native and mutant HD6 (10 mM sodium phosphate buﬀer, pH 7.4). (A) Transmission electron
micrographs of 20 μM HD6 and mutants. Scale bar = 200 nm. (B) Analytical ultracentrifugation of 100 μM F2A and 100 μM F29A. The blue dots
are the −dc/dt data obtained from sedimentation velocity experiments (absorbance at 280 nm). The red lines are the single Gaussian ﬁts obtained
using DCDT+. The summaries of the ﬁts are provided in Supporting Information Tables S4 and S5. (C) CD spectra of 20 μM HD6 (black), F2A
(red), H27A (blue), and F29A (green).
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pattern exhibited by native HD6 (Cys4−Cys31, Cys6−Cys20,
Cys10−Cys30) was conﬁrmed by manual Edman degradation
(Supporting Information Table S3 and Scheme S1). All
experiments were performed with the oxidized species and in
the absence of reducing agents.
Biophysical Characterization Reveals That F2 and F29
Are Essential for HD6 Self-Assembly. Transmission
electron microscopy (TEM) revealed that HD6 spontaneously
self-assembles into higher-order oligomers in aqueous solution.
When we incubated HD6 (2 or 20 μM) at pH 7.4 in 10 mM
sodium phosphate buﬀer and stained the samples with 2%
uranyl acetate, we observed elongated ﬁbril-like structures with
lengths on the micron scale (Figure 2A, Supporting
Information Figure S6). HD6 also formed micron-sized ﬁbrils
at pH 6.4 in 10 mM Tris-maleate buﬀer (Supporting
Information Figure S7). The Tris-maleate buﬀer was employed
in a prior investigation where Salmonella enterica serovar
Typhimurium entrapped by HD6 nanonets in vitro was
visualized by scanning electron microscopy (SEM).21 A
comparison of the TEM images obtained in both buﬀers
revealed a buﬀer eﬀect on ﬁbril morphology. In particular, the
Tris-maleate buﬀer aﬀorded HD6 ﬁbrils that are relatively short
and in relatively low abundance when compared to same
experiment performed in sodium phosphate buﬀer.
TEM of the HD6 mutants provided evidence for varying
degrees of ﬁbril formation under the same conditions (Figure
2A, Supporting Information Figure S7). Notably, mutation of
hydrophobic residues that comprise the hydrophobic pocket
had pronounced eﬀects on ﬁbril formation and morphology.
No ﬁbrils were observed for the F2A or F29A mutants in either
buﬀer, and the V22T and I25T mutants aﬀorded shorter and
thicker ﬁbrils. These observations indicate that these hydro-
phobic residues are important for self-assembly, and that
mutation of either F2 or F29 to Ala prevents ﬁbril formation.
H27A aﬀorded an extensive ﬁbril network characterized by
both thick and thin ﬁbrils whereas fewer and signiﬁcantly
shorter ﬁbril-like structures were observed for H27W. The
latter result is in general agreement with prior studies of H27W,
which reported defective oligomerization properties for this
mutant as ascertained by surface plasmon resonance (SPR) and
X-ray crystallography (PDB: 3QTE).21 However, ﬁbril
formation for H27A contrasts with conclusions drawn from a
SPR investigation of H27A where this mutant was reported to
exhibit the same behavior as H27W.21 From comparison of
H27A and H27W by TEM under our experimental conditions,
as well as in other experiments described below, we conclude
that (i) the nature of the self-assembly varies from mutation to
mutation and (ii) the presence of the bulky Trp residue at
position 27 results in greater perturbation to self-assembly than
loss of H27 and hence loss of either the electrostatic interaction
between this residue and L32 or the putative π−π stacking
interaction with F2.
To further evaluate the quaternary structures of F2A and
F29A, we employed analytical ultracentrifugation (AUC) and
determined the sedimentation coeﬃcients (s20,w) for each
peptide (Supporting Information Tables S4 and S5). At pH 7.4
in 10 mM sodium phosphate buﬀer, single peaks at ca. 0.8 and
1.2 S are observed for F2A (≤160 μM) and F29A (≤160 μM),
respectively, over the range s20,w = 0−2.5 S in the Gaussian ﬁts
of the −dc/dt distributions obtained using DCDT+ (Figure 2B,
Supporting Information Figures S8 and S9, Tables S4 and S5).
The Gaussian ﬁts support the predominance of a single species
for both F2A and F29A over a concentration range of 40−160
μM at pH 7.4. Substitution of phosphate buﬀer with Tris-
maleate buﬀer at pH 6.4 had negligible eﬀect on the s values for
both F2A and F29A (Supporting Information Figures S8 and
S9, Tables S4 and S5). HYDROPRO33 estimated the
sedimentation coeﬃcients of HD6 to be 0.75 S (monomer),
1.17 S (dimer), and 1.83 S (tetramer) using the X-ray crystal
structure of HD619 as a model (Supporting Information Table
S6). A comparison between the experimental and estimated s
values suggests that F2A and F29A predominantly exist as a
monomer and a dimer, respectively, under the conditions
employed for these experiments.
Prior to TEM imaging of the HD6 ﬁbrils, we attempted to
perform a sedimentation velocity experiment with HD6. This
experiment failed because the peptide sedimented within 15
min, even at the lowest possible rotor speed (3000 rpm), and
formed a white coat on the AUC cell attributed to rapid peptide
aggregation. In total, the AUC results support the ﬁndings from
TEM and conﬁrm that F2 and F29 are essential for HD6 self-
assembly in aqueous buﬀer.
Structural diﬀerences between native and mutant HD6 are
also apparent in the CD spectroscopic signatures (Figure 2C,
Supporting Information Figure S10). Native HD6 exhibits
relatively intense features deﬁned by a negative peak at ca. 190
nm and positive peaks centered at 205 and 230 nm. This CD
spectrum diﬀers from those reported for other defensins,
including HD5.29 The HD6 mutants exhibit less intense CD
features than native HD6, and the CD spectra of some mutants
(e.g., F29A) resemble that of HD5. The relatively intense
features in the CD spectrum of native HD6 may provide a
Figure 3. Antibacterial activity assays against L. monocytogenes ATCC 19115, S. aureus ATCC 25923, E. coli ATCC 25922, and S. Typhimurium
ATCC 14028 (mean ± SDM, n = 3). The peptide concentrations were 20 μM. The asterisks indicate no colony formation.
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ﬁngerprint of high-order oligomerization and therefore be used
to identify other defensins that display similar self-assembly.
Mutation of HD6 Does Not Confer Antibacterial
Activity. We questioned whether any of the HD6 mutants
employed in this work, and F2A and F29A in particular, exhibit
antibacterial activity as a result of disrupted oligomerization that
allows smaller, potentially bioactive, species to exist. We
compared the antibacterial activity of HD6 and the six mutants
against four bacterial species. L. monocytogenes ATCC 19115
and Staphylococcus aureus ATCC 25923 were chosen as
representative Gram-positive organisms, whereas E. coli
ATCC 25922 and S. Typhimurium ATCC 14028 were selected
as representative Gram-negative microbes. In these assays,
HD5, which has broad-spectrum antibacterial activity, was
employed as a positive control. The results presented in Figure
3 clearly delineate that neither HD6 nor the mutants exhibit
signiﬁcant antibacterial activity against any of the evaluated
strains at a concentration of 20 μM. Thus, disruption of
quaternary structure that aﬀords lower-order oligomers (e.g.,
F2A, F29A) of the HD6 scaﬀold does not “turn on” a potent
bactericidal killing activity for HD6 against these microbes.
Mutation of Hydrophobic Residues Alters the
Bacterial Agglutination Behavior of HD6. In seminal
studies of HD6 host-defense function, SEM revealed that HD6
entangles S. Typhimurium.21 We reasoned that point mutations
that disrupt HD6 self-assembly likely exhibit a reduced
propensity to entrap and agglutinate bacteria. Thus, we
established a simple bacterial agglutination assay based on
solution turbidity and we employed this assay to probe the
ability of HD6 and its mutants to entrap bacteria and cause
sedimentation (Figure 4, Supporting Information Figures S11−
S13). When we introduced 20 μM HD6 into a bacterial culture
(108 CFU/mL) housed in a sterile plastic cuvette, we observed
bacterial clumping by the eye within 5 min of mixing. These
clumps sedimented to the bottom of the cuvette within about 2
h and clariﬁed the culture medium. This agglutination
phenomenon was observed for both Gram-negative E. coli
and Gram-positive L. monocytogenes. In contrast, agglutination
and sedimentation were not observed for the untreated control;
these cultures remained homogeneous over the course of the
assay. We deﬁned the two phases of the heterogeneous mixture
obtained from HD6 treatment as “supernatant” for the clariﬁed
medium solution in the top portion of the cuvette and
“agglutinate” for the sedimented material at the bottom of the
cuvette (Supporting Information Figure S13). We deﬁned
“resuspension” as the mixture that results from thoroughly
agitating the heterogeneous mixture containing the sedimented
material at the bottom of the cuvette. After incubating the
bacteria and HD6 for 6 h, we determined the CFU/mL of the
supernatant and observed a ca. 1.3-fold log reduction in CFU/
mL relative to the bacteria-only control. Following agitation,
the CFU/mL of the resuspension was comparable to that of the
untreated control (Figure 4B). As expected, the reduction of
CFU/mL in the supernatant is attributed to sedimentation of
bacteria in the cuvette, and not to a bactericidal activity of HD6.
Figure 4. Bacterial agglutination assay for native and mutant HD6. (A) Agglutination of L. monocytogenes ATCC 19115 and E. coli ATCC 25922
treated with HD6 and mutants at diﬀerent concentrations. (B) Plots of colony forming units (CFU/mL) of L. monocytogenes ATCC 19115 and E.
coli ATCC 25922 after treatment with 20 μM peptide for 6 h (mean ± SDM, n = 3).
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We evaluated the ability of the HD6 mutants (0−20 μM) to
agglutinate and sediment L. monocytogenes and E. coli over a 6 h
period (Figure 4, Supporting Information Figures S11 and
S12). On the basis of the resulting sedimentation proﬁles, we
deﬁned three diﬀerent types of behavior for native and mutant
HD6 and grouped the peptides accordingly. One group is
composed of native HD6 and H27A, both of which aﬀorded
similar and relatively rapid bacterial agglutination with the
OD600 values approaching zero in the presence of peptide. The
second group includes mutants that caused bacterial agglutina-
tion, but to a lesser degree than native HD6 and H27A
(Supporting Information Figures S11 and S12). These peptides
are V22T, I25T and H27W, which agglutinated the bacteria
only at relatively high (≥10 μM) peptide concentrations. The
oligomerization-deﬁcient F2A and F29A mutants deﬁne the
third group. The bacterial cultures containing these peptides
remained homogeneous after 6 h even at the highest peptide
concentration evaluated, indicating that these mutants cannot
promote bacterial agglutination and sedimentation under these
conditions. These proﬁles correlate with the results from TEM
where HD6 and H27A formed elongated ﬁbrils; V22T, I25T
and H27W formed ﬁbrils that are smaller and with variable
morphologies; and F2A and F29A did not form any observable
oligomer.
To verify that the decreases in OD600 values observed for
V22T, I25T, H27A and H27W correlated with bacterial
agglutination and sedimentation at the bottom of the cuvette
and not to bacterial cell death, we ascertained the CFU count
for the supernatant and resuspension of each culture treated
with 20 μM peptide for 6 h (Figure 4B). As expected based on
the results of the antibacterial activity assays (Figure 3), this
experiment conﬁrmed that the bacteria remained alive over the
course of the experiment. Moreover, the CFU/mL reductions
observed for the supernatants correlate with the diﬀerences in
the OD600 values before and after sedimentation took place. A
smaller change in OD600 as observed for V22T correlates with a
smaller decrease in CFU/mL for the supernatant. For I25T,
H27A and H27W, each of which caused OD600 to approach
zero at 20 μM of peptide, a CFU/mL reduction similar in
magnitude to that of HD6 was observed.
Hydrophobic Residues Are Needed for HD6 To
Prevent Listeria Invasion of Human T84 Cells. L.
monocytogenes is a pathogenic Gram-positive bacterium that
can colonize the human gastrointestinal tract and cause
foodborne illness in adults as well as meningitis which is a
serious threat to fetuses and newborns.34,35 This species binds
to and invades host cells. We performed a series of L.
monocytogenes invasion assays and determined that HD6 in the
culture medium blocks Listeria invasion into human T84
intestinal epithelial cells. The percentage of Listeria invasion
dropped from ca. 10% to <2% when ≥2.5 μM HD6 was
included in the culture medium (Figure 5). HD6 was previously
shown to block invasion of mammalian cells by two diﬀerent
Gram-negative species, S. Typhimurium and Yersinia enter-
ocolitica.21 Taken together with the current results obtained for
a Gram-positive organism, we conclude that the ability of HD6
to prevent bacterial invasion, at least in vitro, is broad-spectrum
with no apparent selectivity for Gram-negative or Gram-
positive organisms. Moreover, our results indicate that HD6 has
the capacity to provide host defense against the gastrointestinal
pathogen L. monocytogenes.
Like native HD6, H27A provided ≥4-fold reduction in
Listeria invasion over the concentration range evaluated. In
contrast, oligomerization-deﬁcient HD6 mutants F2A and
F29A did not inhibit Listeria invasion over this concentration
range. Moreover, the V22T, I25T and H27W mutants exhibited
attenuated abilities to prevent Listeria invasion compared to
HD6. On the basis of the trends depicted in Figure 5, these
mutants may prevent Listeria invasion at higher peptide
concentrations. Our invasion results for H27W are in good
agreement with previous work where this mutant exhibited
attenuated ability to prevent Salmonella and Yersinia invasion
into mammalian cells.21 We conclude that the hydrophobic
residues and hence self-assembly are important for HD6 to
prevent invasive microbes from entering mammalian cells.
■ SUMMARY AND CONCLUSIONS
In this study, we demonstrate that hydrophobic residues in
HD6 drive its self-assembly and aﬀord innate immune function.
Our results highlight the importance of primary sequence for
defensin function and, in particular, how variable amino acid
sequences between α-defensin family members aﬀord diﬀerent
biophysical properties and biological activity. Of the four
hydrophobic residues evaluated in this work, we discovered that
F2 and F29 are particularly important for both HD6 self-
assembly and biological function.
The results from our solution and TEM experiments, as well
as prior X-ray crystallographic characterization,19 establish that
HD6 forms higher-order structures in the absence of bacteria or
other biomolecules. How the structures observed by TEM
relate to the structure and composition of the HD6 nanonets
entangling bacteria observed21 both in vitro and in vivo requires
further exploration. Along these lines, SEM studies of wild-type
and mutant S. Typhimurium treated with HD6 indicated that
certain cell surface proteins contribute to formation of HD6
nanonets in vitro.21 This observation suggests that bacterial
surface proteins provide a nucleation site. It will be informative
to ascertain whether diﬀerent bacterial species and diﬀerent
bacterial proteins aﬀect the morphology and network of HD6
nanonets, as well as precisely how HD6 interacts with such
proteins. Nanonet maturation as well as the physiological fate
of the nanonet and the entrapped microbes are additional
questions that must be addressed. From a functional stand-
point, we reason that entrapment of bacterial pathogens by
HD6 in the lumen not only prevents bacterial species that
potentially reside and proliferate inside host cells from reaching
this destination and causing infection, but also allows for other
host-defense factors that operate in the intestinal lumen, such
Figure 5. Invasion of human T84 colon epithelial cells by L.
monocytogenes ATCC 19115 in the presence of native and mutant
HD6. The bacteria (2 × 106 CFU/mL) were incubated with the
indicated peptides for 30 min prior to infection of the T84 cells (mean
± SDM, n = 3).
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as other Paneth cell antimicrobials (e.g., HD5) and recruited
neutrophils, to kill them in the extracellular space.
In closing, the hydrophobic eﬀect plays a crucial role in
biological processes that include cell membrane formation,36
protein folding and stabilization,37 and blood coagulation.38 It
also contributes to pathologies associated with protein
misfolding42 as exempliﬁed by the Aβ-peptide (Alzheimer’s
disease)39,40 and α-synuclein (Parkinson’s disease).41,42 HD6
provides a novel example of how Nature employs hydro-
phobicity for a beneﬁcial outcome. Indeed, creating a
biomolecular self-assembly from a 32-residue cysteine-rich
defensin peptide to capture pathogens is a remarkable strategy
for combating infection.
■ EXPERIMENTAL SECTION
General Materials and Methods. All solvents, reagents, and
chemicals were purchased from commercial suppliers and used as
received unless noted otherwise. HD5 was overexpressed and puriﬁed
as previously described.29 All buﬀers, aqueous solutions, and peptide/
oligonucleotide stock solutions were prepared in Milli-Q water (18.2
MΩ cm−1) after it was passed through a 0.22-μm ﬁlter.
Oligonucleotide primers were synthesized by Integrated DNA
technologies and used as received (standard desalting protocol). A
BioRad MyCycler thermocycler was employed for all polymerase chain
reactions (PCR). Chemically competent E. coli TOP10 and BL21-
(DE3) cells were prepared in-house via standard protocols. PfuTurbo
DNA polymerase was purchased from Agilent Technologies. T4 DNA
ligase and all restriction enzymes were purchased from New England
Biolabs. DNA sequencing was performed by dedicated staﬀ in the MIT
Biopolymers Laboratory.
Subcloning, Overexpression, and Puriﬁcation of His6-
proHD6. An E. coli-optimized synthetic gene encoding preproHD6
was obtained from DNA 2.0 in the pJ201 vector (Supporting
Information) The proHD6 nucleotide (333 bp) was PCR ampliﬁed
using pJ201-preproHD6 as a template and the forward and reverse
primers 5′-GAATTCCATATGGAGCCGC TGCAAGCAG-3′ and 5′-
GATCCTCGAGTTACAGACAACAAAAGCGATG-3′, respectively
(restriction site, underlined; stop codon, bold). The PCR reactions
were analyzed by 1% (w/v) agarose gel and a GE Healthcare illustra
GFX PC DNA and Gel Band Puriﬁcation Kit was employed to purify
the PCR products. The products were subsequently digested with
NdeI and XhoI. The resulting fragments were puriﬁed by 1% (w/v)
agarose gel and ligated into the NdeI and XhoI sites of pET28b using
T4 DNA ligase (2 h, rt). The resulting plasmids were transformed into
chemically competent E. coli TOP10 cells and the pET28b-proHD6
plasmid was isolated by using a QIAprep spin miniprep kit (Qiagen).
The plasmid identity was conﬁrmed by DNA sequencing.
The overexpression and puriﬁcation of His6-proHD6 were modiﬁed
from the literature.29 The pET28b-proHD6 plasmid was transformed
into chemically competent E. coli BL21(DE3) cells. Overnight cultures
were prepared by inoculating LB medium containing 50 μg/mL of
kanamycin with single colonies. These cultures were grown to
saturation (37 °C, 150 rpm, 16−18 h) and used to prepare glycerol
freezer stocks. The freezer stocks containing a 1:1 ratio of the
overnight culture and sterile-ﬁltered 50% glycerol in Milli-Q water
were stored at −80 °C. For a given His6-proHD6 overexpression, 50
mL of LB medium containing 50 μg/mL of kanamycin in a 250 mL
baﬄed ﬂask was inoculated with the freezer stock and grown to
saturation (37 °C, 150 rpm, 16−18 h). The resulting culture was
diluted 1:100 into 2 L of fresh LB medum containing 50 μg/mL of
kanamycin in a 4-L baﬄed ﬂask, and the culture was incubated at 37
°C, 150 rpm until OD600 reached ∼0.6. A 400-μL aliquot of 0.5-mM
isopropyl-β-D-1-thiogalactopyranoside (IPTG) was then added to the
2-L culture, and the culture was incubated for an additional 3−4 h (37
°C, 150 rpm) until an OD600 of 1.2−1.5 was achieved. The culture was
centrifuged (3000 rpm for 15 min, 4 °C) and the cell pellets were
collected. Typically, overexpression of His6-proHD6 was performed on
a 12-L scale and the cell pellets from 6 L of culture were combined in
preweighed 50-mL polypropylene tubes (∼2 g/L wet cell weight),
ﬂash frozen in liquid N2, and stored at −80 °C for a period of 1−2
months.
For puriﬁcation of His6-proHD6, each 6-L cell pellet was thawed on
ice and resuspended in 30 mL of cold lysis buﬀer (100 mM Tris-HCl,
6 M GuHCl, pH 8.0). Subsequently, a 1-mL aliquot of phenylmethyl
sulfonyl ﬂuoride (PMSF, 100 mM in EtOH) was added and the
resuspension was transferred to a prechilled stainless steel beaker and
lysed by two rounds of sonication (10% amplitude with pulse on for 1
s and pulse oﬀ for 4 s for a total of 1 min, on ice, Branson sonicator). A
second 1-mL aliquot of PMSF (100 mM in EtOH) was added, and the
cell lysate was clariﬁed by centrifugation (13 000 rpm for 30 min, 4
°C). The resulting supernatant was incubated with prewashed Ni-NTA
resin (Qiagen, from 9 mL of Ni-NTA slurry that was prewashed with
Milli-Q water (3 × 30 mL)) with gentle shaking for 1.5 h at 4 °C. The
resulting mixture was loaded onto a fritted column, and the resin was
washed with 40 mL of cold wash buﬀer (20 mM Tris-HCl, 300 mM
NaCl, 6 M GuHCl, pH 8.0). His6-proHD6 was eluted with 30 mL of
cold elution buﬀer (10 mM Tris-HCl, 300 mM NaH2PO4, 200 mM
NaCl, 1 M imidazole, 6 M GuHCl, pH 6.5). The eluent was
transferred into a dialysis bag (3500 MWCO, Spectrum Laboratories)
and dialyzed against 5% acetic acid (4 L for 12 h, 4 °C) and then 0.1%
acetic acid (4 L for 12 h, 4 °C). The dialyzed solution was
subsequently lyophilized to dryness to aﬀord His6-proHD6 as a white
ﬂuﬀy powder, which was stored at −20 °C. The yield was 26 mg/L
culture. The purity of His6-proHD6 was routinely determined by
analytical HPLC (10−60% B over 30 min, 1 mL/min). The HPLC
retention time and results from LC−MS are shown in Supporting
Information Table S1.
Oxidative Folding. His6-proHD6 was folded by a modiﬁed
literature procedure.29,43 A 120-mg portion of His6-proHD6 was
dissolved in 15 mL of 8 M GuHCl containing 3 mM of glutathione
and 0.3 mM of glutathione disulﬁde. Then, 45 mL of 250 mM
NaHCO3 was added to the solution to adjust the pH to ∼8.3 and
aﬀord a ﬁnal peptide concentration of ∼2 mg/mL. The solution was
incubated at room temperature overnight. The resulting solution was
analyzed by HPLC and mass spectrometry to ensure that His6-
proHD6 was completely folded. The solution was transferred into a
dialysis bag (3500 MWCO) and dialyzed against 10 mM Tris-HCl pH
8.2 (4 L for 12 h, 4 °C) and then 100 mM Tris-HCl pH 8.2 containing
20 mM CaCl2 (4 L for 12 h, 4 °C). The dialyzed solution was adjusted
to a concentration of 1 mg/mL with 100 mM Tris-HCl pH 8.2
containing 20 mM CaCl2 and was then transferred to 50 mL
polypropylene centrifuge tubes and subjected to trypsin-catalyzed
cleavage without further puriﬁcation.
Preparation and Puriﬁcation of Native HD6. An aliquot of a 1-
mg/mL stock solution of TPCK-treated trypsin (Worthington) in
Milli-Q water was added to the solution of His6-proHD6 (1 mg/mL),
which was obtained from oxidative folding as described above, to
aﬀord a ﬁnal trypsin concentration of 0.01 mg/mL. The reaction was
incubated at room temperature for 15 min and subsequently quenched
by addition of 6% TFA/H2O (10% v/v). The resulting solution was
immediately vortexed, ﬂash frozen in liquid N2, and lyophilized to
dryness. The resulting powder was resuspended in 25 mL of 6 M
GuHCl for 15 min and passed through a 0.22-μm ﬁlter. HD6 was
puriﬁed by preparative HPLC using a solvent gradient of 25−33% B
over 18 min. HD6 eluted at 13.4 min and the corresponding fractions
were lyophilized to dryness to provide a white ﬂuﬀy powder. The yield
was 1.9 mg/L culture. The HPLC retention time, and results from
LC−MS are listed in Supporting Information Table S2.
Negative-Staining Transmission Electron Microscopy. For
each sample, a 5-μL aliquot of peptide solution (20 μM in 10 mM
sodium phosphate pH 7.4 or 10 mM Tris-maleate pH 6.4) was placed
onto the carbon-coated surface of a copper grid (400 square mesh,
Electron Microscopy Sciences). After 1 min, the grid was stained with
a 5-μL aliquot of 2% uranyl acetate (UA, Electron Microscopy
Sciences) in Milli-Q water three times and air-dried for at least 15 min
before imaging. A FEI Technai Spirit Transmission Electron
Microscope was employed to collect all transmission electron
micrographs (W.M. Keck Microscopy Facility, Whitehead Institute,
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Cambridge, MA). TEM images were obtained with at least two
independent batches of each peptide and representative images are
presented.
Sedimentation Velocity Experiments. Sedimentation velocity
(SV) experiments were performed to determine the sedimentation
coeﬃcients of the F2A and F29A mutants. A Beckman XL-I Analytical
Ultracentrifuge equipped with an An-50 Ti rotor was used for all SV
experiments. The rotor housed double-sector charcoal-ﬁlled Epon
centerpieces within the sample cells and contained quartz windows. All
SV sample cells contained either 410 μL of buﬀer reference or 400 μL
of peptide solution. In one set of experiments, peptide stock solutions
in Milli-Q water were lyophilized to dryness, dissolved in 400 μL of 10
mM sodium phosphate pH 7.4 or 10 mM Tris-maleate pH 6.4 to
achieve the desired concentrations (40, 50, 100, and 160 μM), and
transferred to SV sample cells. The pH of each solution was measured
to conﬁrm that it remained unchanged. The samples were centrifuged
at 42 000 rpm and 20 °C until sedimentation was complete. The
absorption wavelength used for optical detection was 280 nm. All SV
experiments were conducted with at least two independently prepared
and puriﬁed samples of each peptide and in two independent trials.
The details of data analysis are reported elsewhere.20 The buﬀer
viscosity (η), buﬀer density (ρ), and the partial speciﬁc volume (v)̅
values of F2A and F29A at 20 °C were calculated by employing
SEDNTERP.44 The reported HD6 crystal structure (PDB: 1ZMQ)19
was used in HYDROPRO33 hydrodynamic modeling to calculate
sedimentation coeﬃcients of the HD6 monomer, dimer, and tetramer
(Supporting Information Table S6). It was assumed that the F2A and
F29A mutations would have negligible impact on the calculated
sedimentation coeﬃcients. The buﬀer viscosity (η) and buﬀer density
(ρ) values for water at 20 °C, and a partial speciﬁc volume (v)̅ value of
0.6994 mL/g for HD6 were used in all HYDROPRO calculations. The
experimental sedimentation coeﬃcients of the HD6 mutants were
calculated by ﬁtting the time derivative of the sedimentation velocity
(−dc/dt) data by using DCDT+.45,46 The −dc/dt distribution was
generated from 26 to 34 scans with a peak-broadening limit of 50 kDa
by using DCDT+. The results are reported in Supporting Information
Tables S4 and S5.
Antimicrobial Activity Assays. Bacteria from freezer stocks were
grown to saturation with shaking (37 °C, 16 h) in 5 mL of the
indicated medium (L. monocytogenes ATCC 19115 in Brain Heart
Infusion medium (BHI); S. aureus ATCC 25923, E. coli ATCC 25922,
or S. Typhimurium ATCC 14028 in Tryptic Soy Broth medium (TSB)
without dextrose). The overnight culture was diluted 1:100 into 5 mL
of fresh BHI or TSB and incubated at 37 °C until OD600 of ∼0.6 was
achieved. The resulting culture was centrifuged (3500 rpm for 10 min,
4 °C) and the supernatant was removed. The bacterial pellet was
resuspended in 5 mL of AMA buﬀer (10 mM sodium phosphate, 1%
TSB, pH 7.4). The cell suspension was centrifuged (3500 rpm for 10
min, 4 °C) and the supernatant was discarded. The resulting cell pellet
was resuspended in 5 mL of AMA buﬀer and diluted with AMA buﬀer
to obtain an OD600 value of 0.5 for L. monocytogenes, E. coli, and S.
Typhimurium or 0.6 for S. aureus. For L. monocytogenes ATCC 19115,
the bacterial suspension was further diluted 1:500 with AMA buﬀer in
three steps (1:10 × 1:10 × 1:5). For S. aureus ATCC 25923, the
bacterial suspension was further diluted 1:100 with AMA buﬀer in two
steps (1:10 × 1:10). For E. coli ATCC 25922, the bacterial suspension
was further diluted 1:250 with AMA buﬀer in three steps (1:10 × 1:10
× 1:2.5). For S. Typhimurium ATCC 14028, the bacterial suspension
was further diluted 1:250 with AMA buﬀer in three steps (1:10 × 1:10
× 1:2.5). The diluted cultures were used immediately.
The assays were conducted in 96-well plates. To each well was
added 10 μL of a 10× concentrated aqueous peptide solution (200
μM) or sterile Milli-Q water as a no-peptide control. A 90-μL aliquot
of the diluted bacterial culture was added to each well and the plate
was incubated for 1 h (37 °C, 150 rpm). A 50-μL aliquot from each
well was subsequently added to 450 μL of AMA buﬀer (10−1 dilution).
The resulting solution was vortexed gently and further diluted serially
from 10−2 to 10−4 in 10-fold increments by adding a 100-μL aliquot
from each dilution to 900 μL of AMA buﬀer. A 100-μL aliquot from
each dilution was manually plated on BHI agar plates for L.
monocytogenes or TSB agar plates for S. aureus, E. coli, and S.
Typhimurium. The plates were then incubated at 37 °C for 15 h for E.
coli and S. Typhimurium or 20 h for L. monocytogenes and S. aureus.
The number of colony forming units obtained for each peptide sample
was determined by colony counting. Only plates with 30−200 colonies
were considered in these assays. These assays were performed with at
least two independently prepared and puriﬁed samples of each peptide
and in three independent trials. The resulting averages and standard
deviations are reported.
Bacterial Agglutination Assays. A 5 mL portion of BHI medium
for L. monocytogenes ATCC 19115 or Luria Broth (LB) for E. coli
ATCC 25922 was inoculated with the bacteria from freezer stocks and
grown to saturation with shaking (37 °C, 16 h). The overnight culture
was diluted 1:100 into 10 mL of fresh BHI or LB medium and
incubated at 37 °C until OD600 reached ∼0.6. The resulting culture
was centrifuged (3500 rpm for 10 min, 4 °C) and the supernatant was
removed. The bacterial pellet was resuspended in 10 mL of 50%
Mueller-Hinton Broth pH 7.4 (MHB, Fluka). The cell suspension was
centrifuged (3500 rpm for 10 min, 4 °C) and the supernatant was
discarded. The resulting bacterial pellet was resuspended in 10 mL of
50% MHB and further diluted with 50% MHB to obtain an OD600
value of 0.25. The diluted bacterial cultures were immediately
employed for the agglutination assays.
For all agglutination assays, a 450-μL aliquot of the bacterial culture
(OD600 ∼ 0.25) was added to 50 μL of a 10× concentrated aqueous
peptide solution (50, 100, or 200 μM) or sterile Milli-Q water as a no-
peptide control and immediately transferred to an EtOH-sterilized
two-sided disposable polystyrene cuvette (VWR International). The
OD600 values were measured at the indicated time points and plotted
versus time to aﬀord a sedimentation curve. After 6 h, a 100-μL aliquot
from each cuvette containing 20 μM of each peptide was diluted with
900 μL of 11 mM sodium phosphate pH 7.4, vortexed gently, and
serially diluted from 10−2 to 10−7 in 10-fold increments by adding a
100-μL aliquot from each dilution to 900 μL of the buﬀer. If there was
bacterial sedimentation in the cuvette, a 100-μL aliquot was taken from
the supernatant for serial dilutions. Then, 100 μL of fresh 50% MHB
was added to the cuvette and the bacterial aggregate was resuspended.
Another 100-μL aliquot was subsequently taken from the resulting
suspension for serial dilutions. To determine the number of colony
forming units for each peptide treatment, a 100-μL aliquot from each
dilution was manually plated on BHI agar plates for L. monocytogenes
or LB agar plates for E. coli and incubated at 37 °C for 20 or 15 h,
respectively. Only plates with 30−200 colonies were considered in
these assays. All assays were performed with at least two independently
prepared and puriﬁed samples of each peptide and in three
independent trials. The resulting averages with standard deviations
are reported.
General Cell Culture Methods. Human colon epithelial T84 cells
(ATCC CCL-248) were obtained from the American Type Culture
Collection (ATCC) and grown in 1:1 Dulbecco’s modiﬁed Eagle
medium (DMEM) and Ham’s F12 medium containing 2.5 mM L-
glutamine, 15 mM HEPES, 0.5 mM sodium pyruvate, and 1.2 g/L
sodium bicarbonate, and supplemented with 10% fetal bovine serum
and 1% penicillin/streptomycin. Cells were cultured at 37 °C and 5%
CO2 according to the instructions from ATCC. The growth medium
and all supplements were purchased from ATCC.
Listeria Invasion Assays. These assays were conducted by
modifying reported literature protocols.21,47,48 L. monocytogenes
ATCC 19115 from freezer stocks were grown overnight with shaking
(37 °C, 16 h) in 5 mL of BHI medium. The overnight culture was
diluted 1:100 into 5 mL of fresh BHI medium and incubated at 37 °C
until OD600 of ∼0.6 was achieved. The resulting culture was
centrifuged (3500 rpm for 10 min, 4 °C) and the supernatant was
removed. The bacterial pellet was resuspended in 5 mL of serum- and
antibiotic-free 1:1 DMEM/F12. The resulting suspension was
centrifuged (3500 rpm for 10 min, 4 °C) and the supernatant was
removed. The bacterial pellet was resuspended in 5 mL of serum- and
antibiotic-free 1:1 DMEM/F12 and diluted with the medium to aﬀord
an OD600 value of 0.5. The resulting suspension was further diluted
1:150 into 3 mL of the fresh medium. A 190-μL aliquot of the diluted
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bacterial culture was immediately added to 10 μL of a 20×
concentrated aqueous peptide solution (50, 100, or 200 μM) or
sterile Milli-Q water as a no-peptide control and incubated at room
temperature for 30 min.
T84 cells between passages 59 and 73 were cultured in 75 cm2
rectangular canted neck cell culture ﬂasks (Corning) to approximately
95% conﬂuency and treated with 3 mL of trypsin−EDTA (Corning).
A 12-mL portion of fresh media was added to the detached cells, and
the T84 cell suspension was centrifuged (600 rpm for 5 min, 37 °C).
The supernatant was discarded and the cell pellet was resuspended in
6 mL of the fresh culture medium. The concentration of cells was
quantiﬁed by using a manual hemocytometer (VWR International)
and adjusted to 2 × 105 cells/mL. A 500-μL aliquot of T84 cells was
then added to 24-well Costar tissue culture plates (Corning) and
incubated at 37 °C and 5% CO2 for 24 h. With this cell density, the
monolayers were ∼80% conﬂuent at the time of the experiment. With
cells at this conﬂuency, the medium was discarded and the cells were
washed twice with 500 μL of phosphate buﬀered saline (PBS) without
calcium or magnesium (ATCC) and bathed in 500 μL of serum- and
antibiotic-free 1:1 DMEM/F12. After a 2-h equilibration in serum- and
antibiotic-free medium, the medium was discarded. The T84 cells were
washed twice with 500 μL of PBS and infected with 200 μL of peptide-
treated L. monocytogenes (multiplicity of infection, MOI = 10) at 37 °C
and 5% CO2. MOI is a ratio of the number of bacterial cells to
mammalian cells when infection is initiated. A 100-μL aliquot of the
diluted bacterial culture was used to determine the number of
inoculum by colony counting as described below. After 1.5 h of
infection, the medium was removed and the T84 cells were washed
twice with 500 μL of PBS. To kill any remaining extracellular bacteria,
the T84 cells were subsequently incubated in 200 μL of serum-free 1:1
DMEM/F12 containing 100 μg/mL of gentamycin for 1.5 h at 37 °C
and 5% CO2. After 1.5 h, the medium was removed and the T84 cells
were washed twice with 500 μL of PBS. The T84 cells were then
incubated in 200 μL of sterile-ﬁltered 1% Triton X-100 (EMD) in PBS
for 10 min at rt.
A 50-μL aliquot from each well was diluted with 450 μL of 11 mM
sodium phosphate pH 7.4, vortexed gently, and serially diluted from
10−2 to 10−4 in 10-fold increments by adding a 100-μL aliquot from
each dilution to 900 μL of the fresh buﬀer. To determine the number
of invading bacteria for each peptide treatment, a 100-μL aliquot from
each dilution was manually plated on BHI agar plates and incubated at
37 °C for 20 h. Only plates with 30−200 colonies were considered in
these assays. The percentage of invasion represents the ratio of the
number of invading bacteria to the number of inoculated bacteria. All
assays were performed with at least two independently prepared and
puriﬁed samples of each peptide and in three independent trials. The
resulting averages and standard deviations are reported.
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